Shotlee LogoShotlee
Blog
Skip to main content
AllOzempicMounjaroRetatrutideGLP-1 MedicationsWeight ManagementHealth & WellnessWeight LossMetabolic Health

Latest Articles

Latest Articles

Showing 9 / 1088 Ozempic articles

Wegovy and Ozempic May Slash Deadly Heart Attack Complication Risk
GLP-1 Medications

Wegovy and Ozempic May Slash Deadly Heart Attack Complication Risk

Researchers from the University of Bristol and UCL have found that GLP-1 drugs like Wegovy and Ozempic could dramatically reduce the risk of 'no-reflow,' a deadly complication affecting up to half of heart attack patients. By relaxing tiny blood vessels, these medications may prevent further heart damage even if given by paramedics on-site. This study opens doors for repurposing popular obesity and diabetes treatments in emergency cardiac care.

Shotlee··6 min read
Semaglutide May Double nAMD Risk in Older Adults: Study
GLP-1 Medications

Semaglutide May Double nAMD Risk in Older Adults: Study

New research from the University of Toronto reveals that older adults with diabetes taking semaglutide (Ozempic and Wegovy) face more than double the risk of neovascular age-related macular degeneration (nAMD), a severe form of vision loss. The study, published in JAMA Ophthalmology, highlights increased risks with longer use and certain comorbidities. Patients should prioritize regular eye exams to catch issues early.

Shotlee··5 min read
Survey: 3M Canadians on GLP-1 Drugs Like Ozempic, Reshaping Eating and Spending
GLP-1 Medications

Survey: 3M Canadians on GLP-1 Drugs Like Ozempic, Reshaping Eating and Spending

A new Leger Healthcare survey estimates that around three million Canadian adults are currently using GLP-1 medications such as Ozempic or Mounjaro. These drugs are not only curbing appetite and cravings but also transforming daily spending habits, from less restaurant takeout to more fresh produce and gym memberships. Weight loss tops the reasons, but barriers like cost keep millions from starting.

Shotlee··5 min read
Beyond Weight Loss: Ozempic Linked to Migraine Reduction, Study
GLP-1 Medications

Beyond Weight Loss: Ozempic Linked to Migraine Reduction, Study

GLP-1 receptor agonists like Ozempic, used for diabetes and weight loss, may offer relief for chronic migraine sufferers by cutting emergency department visits and medication needs. A new study compares them to topiramate, revealing promising associations in stabilizing migraine burden. Presented at the American Academy of Neurology's 2026 meeting, these findings highlight unexpected benefits beyond weight loss.

Shotlee··5 min read